Nufarm's Earnings View Could Be Conservative -- Market Talk

Dow Jones
Apr 16

0013 GMT - Nufarm's annual earnings could positively surprise, signals Morgans. Nufarm pointed to 1H underlying Ebitda of A$239 million-A$244 million, up 17% on a year ago at the midpoint of the range. Nufarm has benefited from higher Crop Protection margins, growth in Hybrid Seeds and a stronger performance from its emerging Omega-3 and bioenergy platforms. It's also targeting an additional A$50 million of cost savings. "Given the appreciation in active ingredient and fish oil prices, Nufarm's previous FY26 guidance could prove to be conservative," analyst Belinda Moore says. Morgans keeps a buy call on Nufarm, partly on expectations that the crop-chemicals industry will continue to consolidate in coming years. It wouldn't be surprised if Nufarm becomes an M&A target. (david.winning@wsj.com; @dwinningWSJ)

 

(END) Dow Jones Newswires

April 15, 2026 20:13 ET (00:13 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10